TrialJournal of the American Society of Nephrology : JASN2019

Efficacy and Safety of Tenapanor in Patients with Hyperphosphatemia Receiving Maintenance Hemodialysis: A Randomized Phase 3 Trial.

Geoffrey A Block et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.